BioNTech

BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based... Wikipedia

• Type:  Public
• Traded as:  NASDAQ: BNTX
• ISIN:  [ ISIN: [ US09075V1026]]
• Industry:  Biotechnology
• Founded:  2008
• Founders:  Uğur Şahin, Özlem Türeci, Christoph Huber, Andreas Strüngmann, Thomas Strüngmann, Michael Motschmann, Helmut Jeggle
• Number of locations:  8(2022)
• Area served:  Worldwide
• Key people:  Uğur Şahin (CEO), Özlem Türeci (CMO), Sean Marett (CBO, CCO), Sierk Poetting (COO)
• Products:  BNT162b2
• Services:  Immunotherapy
• Revenue:  €3.819 billion(2023)
• Operating income:  €690.4 million(2023)
• Total assets:  €23.01 billion(2023)
• Total equity:  €20.25 billion(2023)
• Number of employees:  6,133(2023)
• Website:  biontech.com
• Data source:  DuckDuckGo